End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.5 TWD | +4.84% |
|
-0.31% | +2.36% |
03-26 | Tatung Fine Chemicals Co. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Tatung Fine Chemicals Co. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 197.1 | 201.7 | 322 | 666.5 | 411.3 | 492.7 |
Enterprise Value (EV) 1 | 280.4 | 288.7 | 326.9 | 730.4 | 448.8 | 509.5 |
P/E ratio | -0.82 x | 260 x | -20.7 x | 124 x | 75.7 x | 114 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 0.7 x | 0.78 x | 1.34 x | 2.22 x | 1.43 x | 1.88 x |
EV / Revenue | 1 x | 1.12 x | 1.36 x | 2.43 x | 1.56 x | 1.95 x |
EV / EBITDA | -2.13 x | 36.5 x | -31.5 x | 147 x | 38.2 x | 69.4 x |
EV / FCF | -7.22 x | 9.57 x | 3.89 x | -44.5 x | 71.3 x | 20 x |
FCF Yield | -13.8% | 10.5% | 25.7% | -2.25% | 1.4% | 5.01% |
Price to Book | 1.45 x | 1.59 x | 2.85 x | 5.67 x | 3.32 x | 3.96 x |
Nbr of stocks (in thousands) | 77,596 | 77,596 | 77,596 | 77,596 | 77,596 | 77,596 |
Reference price 2 | 2.540 | 2.600 | 4.150 | 8.590 | 5.300 | 6.350 |
Announcement Date | 15/04/19 | 23/04/20 | 30/03/21 | 20/04/22 | 31/03/23 | 26/03/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 281.4 | 258.5 | 239.5 | 300.5 | 288.2 | 261.4 |
EBITDA 1 | -131.5 | 7.898 | -10.37 | 4.956 | 11.74 | 7.341 |
EBIT 1 | -140.1 | 1.223 | -17.08 | -2.117 | -3.386 | 0.455 |
Operating Margin | -49.78% | 0.47% | -7.13% | -0.7% | -1.17% | 0.17% |
Earnings before Tax (EBT) 1 | -220.5 | 3.467 | -15.17 | 6.835 | 5.981 | 4.619 |
Net income 1 | -241.5 | 0.988 | -15.56 | 5.368 | 5.464 | 4.322 |
Net margin | -85.83% | 0.38% | -6.5% | 1.79% | 1.9% | 1.65% |
EPS 2 | -3.113 | 0.0100 | -0.2006 | 0.0692 | 0.0700 | 0.0557 |
Free Cash Flow 1 | -38.81 | 30.18 | 84.05 | -16.4 | 6.296 | 25.53 |
FCF margin | -13.79% | 11.67% | 35.09% | -5.46% | 2.18% | 9.77% |
FCF Conversion (EBITDA) | - | 382.1% | - | - | 53.63% | 347.77% |
FCF Conversion (Net income) | - | 3,054.47% | - | - | 115.23% | 590.69% |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 15/04/19 | 23/04/20 | 30/03/21 | 20/04/22 | 31/03/23 | 26/03/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 83.3 | 86.9 | 4.85 | 63.9 | 37.6 | 16.8 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | -0.6334 x | 11.01 x | -0.4674 x | 12.88 x | 3.2 x | 2.283 x |
Free Cash Flow 1 | -38.8 | 30.2 | 84 | -16.4 | 6.3 | 25.5 |
ROE (net income / shareholders' equity) | -93.7% | 0.75% | -13% | 4.65% | 4.52% | 3.48% |
ROA (Net income/ Total Assets) | -14.3% | 0.17% | -2.9% | -0.36% | -0.58% | 0.09% |
Assets 1 | 1,692 | 566.8 | 536.9 | -1,487 | -938.5 | 5,073 |
Book Value Per Share 2 | 1.750 | 1.630 | 1.460 | 1.520 | 1.600 | 1.600 |
Cash Flow per Share 2 | 1.590 | 0.5300 | 1.440 | 0.8500 | 0.9800 | 1.020 |
Capex 1 | 7.89 | 3.12 | 3.52 | 7.9 | 1.43 | 3.48 |
Capex / Sales | 2.8% | 1.21% | 1.47% | 2.63% | 0.5% | 1.33% |
Announcement Date | 15/04/19 | 23/04/20 | 30/03/21 | 20/04/22 | 31/03/23 | 26/03/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+2.36% | 15.47M | |
+4.46% | 82.64B | |
-13.84% | 34.13B | |
-10.56% | 31.48B | |
+2.45% | 14.73B | |
-14.28% | 14.98B | |
-21.41% | 10.88B | |
+6.54% | 7.99B | |
-13.85% | 7.26B | |
+1.95% | 3.25B |
- Stock Market
- Equities
- 4738 Stock
- Financials Tatung Fine Chemicals Co.